(R)-2,2',3,3'-Tetrahydro-6,6'-bis(triphenylsilyl)-1,1'-spirobi[1H-indene]-7,7'-diol
|
K037535-100mg
|
≥98%,99%e.e. |
1372719-97-5 |
100mg
|
¥ 3421.0
|
5-7天 |
科威 |
(R)-2,2',3,3'-Tetrahydro-6,6'-di-9-phenanthrenyl-1,1'-spirobi[1H-indene]-7,7'-diol
|
K037534-100mg
|
≥98%,99%e.e. |
1372719-96-4 |
100mg
|
¥ 4806.0
|
5-7天 |
科威 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037533-100mg
|
≥98%,99%e.e. |
1372719-95-3 |
100mg
|
¥ 6811.0
|
5-7天 |
科威 |
(11aR)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037532-50mg
|
≥98%,99%e.e. |
1372719-94-2 |
50mg
|
¥ 3732.0
|
5-7天 |
科威 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037531-100mg
|
≥98%,99%e.e. |
1372719-93-1 |
100mg
|
¥ 5553.0
|
5-7天 |
科威 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
K037531-50mg
|
≥98%,99%e.e. |
1372719-93-1 |
50mg
|
¥ 3885.0
|
5-7天 |
科威 |
2-甲基-5-溴-2H-1,2,3-三唑-4-甲酸甲酯
|
K037530-1g
|
95% |
1372711-70-0 |
1g
|
¥ 8561.0
|
5-7天 |
科威 |
2-甲基-5-溴-2H-1,2,3-三唑-4-甲酸甲酯
|
K037530-250mg
|
95% |
1372711-70-0 |
250mg
|
¥ 3329.0
|
5-7天 |
科威 |
4-氯-3-甲氧基苯乙腈
|
K037529-100mg
|
98% |
13726-21-1 |
100mg
|
¥ 895.0
|
5-7天 |
科威 |
4-氯-3-甲氧基苯乙腈
|
K037529-25mg
|
98% |
13726-21-1 |
25mg
|
¥ 373.0
|
5-7天 |
科威 |
(4-氯-3-甲氧基苯基)甲醇
|
K037528-1g
|
97% |
13726-17-5 |
1g
|
¥ 1178.0
|
5-7天 |
科威 |
(4-氯-3-甲氧基苯基)甲醇
|
K037528-250mg
|
97% |
13726-17-5 |
250mg
|
¥ 492.0
|
5-7天 |
科威 |
4-氯-3-甲氧基苯甲醛
|
K037527-1g
|
98% |
13726-16-4 |
1g
|
¥ 162.0
|
5-7天 |
科威 |
4-氯-3-甲氧基苯甲醛
|
K037527-250mg
|
98% |
13726-16-4 |
250mg
|
¥ 90.0
|
5-7天 |
科威 |
4-乙基-5-氟嘧啶
|
K037526-1g
|
97% |
137234-88-9 |
1g
|
¥ 203.0
|
现货 |
科威 |
4-乙基-5-氟嘧啶
|
K037526-250mg
|
97% |
137234-88-9 |
250mg
|
¥ 85.0
|
现货 |
科威 |
6-乙基-5-氟嘧啶-4(3H)-酮
|
K037525-1g
|
98% |
137234-87-8 |
1g
|
¥ 118.0
|
现货 |
科威 |
7-巯基-4-甲基-2H-吡喃-2-酮
|
K037524-250mg
|
98% |
137215-27-1 |
250mg
|
¥ 2251.0
|
5-7天 |
科威 |
7-巯基-4-甲基-2H-吡喃-2-酮
|
K037524-50mg
|
98% |
137215-27-1 |
50mg
|
¥ 750.0
|
5-7天 |
科威 |
2,5-二甲基-1,4-苯醌
|
K037523-25g
|
98% |
137-18-8 |
25g
|
¥ 6420.0
|
5-7天 |
科威 |
2,5-二甲基-1,4-苯醌
|
K037523-5g
|
98% |
137-18-8 |
5g
|
¥ 1617.0
|
5-7天 |
科威 |
(1S,2R)-2-(Boc-氨基)环戊烷甲酸
|
K037522-1g
|
≥97% |
137170-89-9 |
1g
|
¥ 4519.0
|
5-7天 |
科威 |
(1S,2R)-2-(Boc-氨基)环戊烷甲酸
|
K037522-250mg
|
≥97% |
137170-89-9 |
250mg
|
¥ 1902.0
|
5-7天 |
科威 |
5-甲酰基-1H-咪唑-4-羧酸乙酯
|
K037521-250mg
|
97% |
137159-36-5 |
250mg
|
¥ 1061.0
|
5-7天 |
科威 |